MPO and breast neoplasm: Levels of malondialdehyde MDA (end-product of lipid peroxidation), myeloperoxidase MPO activity (lysosomal oxidising agent) and nitric oxide (inflammatory marker), that were significantly increased in Wistar rats bearing breast tumours, were ameliorated in rats treated with nanoceria [82].